Skip to main content
. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7
Trial name or title Comparison of the efficacy and safety of varenicline versus placebo for smoking cessation among HIV‐infected patients (Inter‐ACTIV)
Methods Randomised quadruple‐blind placebo‐controlled trial
Participants 254 smokers diagnosed with HIV infection
Interventions Varenicline 1.0 mg x 2/day vs placebo for 12 weeks
Outcomes CAR for wks 9 ‐ 48
Starting date October 2009
Contact information Patrick Mercie
Notes